Categories: CauseDevelopmentDrugFutureInvestmentITLifePlatformSexTechTime
A clinical stage drug development company focusing on women’s health. World leading innovator in the endometriosis field.
Investors 4
Funding Rounds 3
| Date | Series | Amount | Investors |
| 23.07.2019 | - | $5.58M | - |
| 05.09.2018 | - | $4.65M | - |
| 19.03.2018 | - | $3.7M | - |
Mentions in press and media 3
| Date | Title | Description |
| 23.07.2019 | Forendo Pharma Receives €5M Investment from Sunstone Life Science Ventures | Forendo Pharma, a Turku, Finland-based clinical stage drug development company focusing on novel treatments in women’s health, received a €5 million investment from Sunstone Life Science Ventures.
Sunstone joined the existing international ... |
| 05.09.2018 | Forendo Pharma Raises Additional €4M in Funding | Forendo Pharma, a Turku and Oulu, Finland-based clinical stage drug development company focusing on novel treatments in women’s health, raised an additional €4m of funding.
Vesalius Biocapital III Partners made the investment, which is in a... |
| 19.03.2018 | Forendo Pharma Receives €3M Loan from Business Finland | Forendo Pharma, a Turku, Finland-based drug development company developing novel oral treatments for endometriosis patients, received a €3 million R&D loan from Business Finland.
The funds will be used for the development of a novel dru... |
Reviews 0
